Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Darleukin |
Synonyms | |
Therapy Description |
Darleukin is an immunocytokine comprising a recombinant antibody targeting the ED-B domain of fibronectin fused to human IL-2, which delivers the cytokine to developing blood vessels in the tumor and may induce an anti-tumor immune response (PMID: 11861281). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Darleukin | L19-IL2|L19IL2|bifikafusp alfa | Darleukin is an immunocytokine comprising a recombinant antibody targeting the ED-B domain of fibronectin fused to human IL-2, which delivers the cytokine to developing blood vessels in the tumor and may induce an anti-tumor immune response (PMID: 11861281). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|